
Nephrologist

No OPD information available
Chronic Kidney Disease
End-Stage Renal Disease (ESRD)
COVID-19
Diabetic Nephropathy
Glomerulonephritis
Heart Attack
IgA Nephropathy
Interstitial Nephritis
Kidney Transplant
Sepsis
Severe Acute Respiratory Syndrome (SARS)
Type 2 Diabetes (T2D)
Wilson Disease
Sradha S. Kotwal is a medical professional who helps people with different health problems like Chronic Kidney Disease, End-Stage Renal Disease (ESRD), COVID-19, Diabetic Nephropathy, Glomerulonephritis, Heart Attack, IgA Nephropathy, Interstitial Nephritis, Kidney Transplant, Sepsis, Severe Acute Respiratory Syndrome (SARS), Type 2 Diabetes (T2D), and Wilson Disease.
Sradha S. Kotwal uses special skills and treatments to take care of patients. They are good at helping people with kidney issues, diabetes, and other serious illnesses. Patients trust Sradha S. Kotwal because they are caring and explain things in a way that is easy to understand.
Sradha S. Kotwal stays updated with the latest medical knowledge and research to provide the best care for patients. They read new studies and attend conferences to learn about new treatments and technologies.
Sradha S. Kotwal works well with other medical professionals. They collaborate with colleagues to give the best care possible to patients. By working together, they can come up with better solutions for complex health problems.
Sradha S. Kotwal's work has positively impacted many patients' lives. For example, they have helped improve the health of people with kidney disease and diabetes. Their research has also been published in medical journals, showing their expertise in the field.
Overall, Sradha S. Kotwal is a dedicated medical professional who uses their skills and knowledge to help patients with various health conditions. Patients trust them because they communicate well, stay updated with the latest research, and work effectively with other medical professionals to provide the best possible care.
Enrollment Status: Completed
Published: June 22, 2023
Intervention Type: Drug, Other
Study Drug:
Study Phase: Phase 2
